Brief: Cynata Therapeutics Posts HY Loss Attributable Of A$1.1 Million
25/02/2022 07:31
Feb 25 (Reuters) - Cynata Therapeutics Ltd CYP.AX :
* HY LOSS ATTRIBUTABLE A$1.1 MILLION VERSUS LOSS OF A$4.8
MILLION
* HY REVENUE AND OTHER INCOME ABOUT A$7.0 MILLION VERSUS
A$118,151
Source text for Eikon: ID:nASX7cR1Jv
Further company coverage: CYP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cynata Therapeutics
See all newsBrief: Cynata Therapeutics Says Firm Commitments Received To Raise Further A$550,000 Via Placement
Brief: Cynata Therapeutics Enters Consultancy Agreement With LIR Bio Advisory
Brief: Cynata Therapeutics Establishes Share Sale Facility For Unmarketable Parcel Holders
Brief: Cynata Therapeutics Terminates Of At-The-Market Subscription Deed
Brief: Cynata Therapeutics Posts FY2026 Loss From Ordinary Activities After Tax A$9.1 Million